Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
about
Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyPhase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis.Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.Recent advances in the management of AL Amyloidosis.Novel strategies for the diagnosis and treatment of cardiac amyloidosis.Systemic amyloidosis: novel therapies and role of biomarkers.Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib.Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis.Treating advanced cardiac damage in light chain amyloidosis: still an unmet need.New concepts in the treatment and diagnosis of amyloidosis.Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study.Light Chain Amyloidosis.Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment.Novel Therapies in Light Chain Amyloidosis.Recent advances in understanding and treating immunoglobulin light chain amyloidosis
P2860
Q30276115-88AA6FA5-E4F7-41DB-8049-52168D1E1CE9Q30278687-2A73FEAF-945C-42F7-B8C5-FA410F41D130Q33427726-FE69BB3B-0142-40A5-A57C-002508019D03Q37059137-53CC131C-57AA-4EDF-88D3-56194582B798Q38376616-214DB404-8A4E-4FA1-8127-12832E45EAF1Q38613822-D927C3DA-AF84-4204-A316-14002B65BB73Q38614967-147AAEB7-4918-48C5-90AF-FE2463D892F6Q38829923-C073F7C0-CAE2-4E01-A4EE-501A83702F7AQ38959241-8EA5CA05-48B6-4E92-91FA-B0AFBDD0D38FQ39024208-09D5E76F-B7AA-4F64-B245-AA51246CC26DQ40261261-B256BA2F-60DF-47DB-AB7B-32D067ED0117Q40362742-BA170EDB-479A-41A9-86B6-C54DC621D23FQ41080053-65539378-3DE6-4280-8AE7-DAB788A15B71Q41593651-93FF24DF-81F6-414E-8B61-92788455BFEBQ42292795-6D30EC53-0B48-4321-A11A-CB0EF81AE650Q43134938-2BDD1B78-7C8D-4E68-94C3-13974A95787BQ47561519-7B644F2C-5E07-4544-934A-51EE46D8795AQ48614453-CA129D0E-C5AE-458B-A3A8-B3B6B060C9E8Q49563182-A0DD94BA-889A-4004-A009-880A9FE561B2Q52659305-8182F6B3-67C0-45F0-8E53-2774E35B3B3FQ53562807-8E4377A2-90EA-41AB-90BC-AE6A78E9CB3BQ55127439-AD4718B0-42D7-4B80-AF83-D48C15BECB8DQ57166910-B1BA00F1-3C18-4D5A-A4AA-7070A01AF148
P2860
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
description
im Juli 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 25 July 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2014
@uk
name
Melphalan and dexamethasone wi ...... –control study on 174 patients
@en
Melphalan and dexamethasone wi ...... –control study on 174 patients
@nl
type
label
Melphalan and dexamethasone wi ...... –control study on 174 patients
@en
Melphalan and dexamethasone wi ...... –control study on 174 patients
@nl
prefLabel
Melphalan and dexamethasone wi ...... –control study on 174 patients
@en
Melphalan and dexamethasone wi ...... –control study on 174 patients
@nl
P2093
P2860
P50
P356
P1433
P1476
Melphalan and dexamethasone wi ...... -control study on 174 patients
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2014.227
P50
P577
2014-07-25T00:00:00Z